Dynamic alterations of plasma cell free DNA in response to chemotherapy in children with neuroblastoma

Dynamic alterations of plasma cell free DNA in response to chemotherapy in children with neuroblastoma

Abstract Background To improve cure rates for neuroblastoma (NB), it is important and necessary to evaluate therapy response. Our investigation focuses on using plasma cell free DNA (cfDNA) as a biomarker to determine tumor burden and minimal residual disease (MRD) of NB patients during chemotherapy...

Full description

Bibliographic Details
Main Authors: Yan Su, Lijun Wang, Xisi Wang, Zhixia Yue, Tianyu Xing, Wen Zhao, Qian Zhao, Chao Duan, Cheng Huang, Yi Han, Lihua Qiu, Xianfeng Cheng, Yi Liu, Xiaoli Ma
Format: Article
Language:English
Published: Wiley 2019-04-01
Series:Cancer Medicine
Subjects:
dynamic changes
minimal residual disease
neuroblastoma
plasma cell free DNA
therapy response
Online Access:https://doi.org/10.1002/cam4.2045

Internet

https://doi.org/10.1002/cam4.2045

Similar Items